Now showing items 1-3 of 3

    • Antihypertensive medicine use in the Baltic states between 2008 and 2018 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn; Taxis, Katja (Pharmacoepidemiology and drug safety: Supplement: Special Issue: Abstracts of the 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, September 16–17, 2020, 2020)
    • One-year treatment non-persistence rates in hypertensive patients in Lithuania 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn Gunnar Erik Evert; Taxis, Katja (Research in social and administrative pharmacy: Conference Abstracts: Next Chapter in Patient Care 2021: patient-centered approach and digital innovation inhealthcare (NCPC 2021) 7-9 April 2022, Parnu, Estonia, 2022)
    • The initiation of treatment and one-year treatment non-persistence rates in hypertensive patients in Lithuania 

      Trečiokienė, Indrė; Bratčikovienė, Nomeda; Gulbinovič, Jolanta; Wettermark, Bjorn; Taxis, Katja (Pharmacoepidemiology and drug safety: Supplement: Abstracts of the 38th International Conference on Pharmacoepidemiology: Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community, August 26–28, 2022, Copenhagen, Denmark, 2022)
      There is extensive evidence on benefits of antihypertensive treatment, yet many patients with hypertension do not reach therapy goals. Poor persistence to antihypertensive drug therapy has shown to be an important reason ...